Immunotherapy: Cancer Care Gets Customized

Timothy L. Cannon, MD, is board certified in medical oncology and hematology, and has a special interest in managing gastrointestinal cancers. Dr. Cannon is the clinical director and moderator of Inova’s weekly molecular tumor board, which matches patients with targeted therapies based on molecular diagnostics.      Tiffani A. DeMarco, MS, CGC, is a board-certified…

Read More

“Inova partners with Institute for Systems Biology,” Washington Business Journal, Septebmer 25, 2013

Inova Translational Medicine Institute has signed a partnership agreement with the Institute for Systems Biology to develop tools to collect and analyze biological information now being collected by the Inova institute’s researchers for a 5,000-family longitudinal study to analyze genomic diseases in young children. Read more

Read More